Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy

Andrew P. Hearn, Oliver D. Hug, Ziana A. Somani, Joanne Kavanagh, Grainne d'Ancona, Cris Roxas, Linda Green, Louise Thomson, Mariana Fernandes, Brian D. Kent, Jaideep Dhariwal, Alexandra M. Nanzer, David J. Jackson

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Article number2100166
JournalThe European respiratory journal
Issue number6
Publication statusPublished - 1 Jun 2021

Cite this